HWM
ATYR

Hohimer Wealth Management’s aTyr Pharma ATYR Stock Holding History

Hohimer Wealth Management’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.8K Sell
55,000
-45,000
-45% -$29.4K ﹤0.01% 390
2026
Q1 		$78K Buy
+100,000
New +$84.4K 0.01% 376

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hohimer Wealth Management's ATYR Position: Q2 2026 in Review

Hohimer Wealth Management reduced its aTyr Pharma (ATYR) stake by 45% in Q2 2026, selling an estimated $29.4K and leaving 55,000 shares worth $32.8K. The position accounts for ﹤0.01% of the portfolio, ranked #390.

Hohimer Wealth Management first reported a position in ATYR in Q1 2026 and has held it in 2 quarters since. The position peaked at $78K in Q1 2026. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • Hohimer Wealth Management held 55,000 shares of aTyr Pharma worth $32.8K as of Q2 2026.
  • Hohimer Wealth Management sold 45,000 aTyr Pharma shares in Q2 2026, an estimated $29.4K.
  • aTyr Pharma made up ﹤0.01% of Hohimer Wealth Management's portfolio in Q2 2026, its #390 holding.
  • Hohimer Wealth Management first reported a position in aTyr Pharma in Q1 2026 and has held it in 2 quarters since.
  • Hohimer Wealth Management's aTyr Pharma position peaked at $78K in Q1 2026.
  • 90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Hohimer Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.